Insider Transactions in Q1 2025 at Cognition Therapeutics Inc (CGTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2025
|
John Brendan Doyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,723
-0.41%
|
$0
$0.59 P/Share
|
|
Feb 15
2025
|
Anthony Caggiano Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,296
-1.25%
|
$0
$0.59 P/Share
|
|
Feb 15
2025
|
Lisa Ricciardi CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,619
-0.74%
|
$0
$0.59 P/Share
|
|
Feb 04
2025
|
Lisa Ricciardi CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
631,300
+41.4%
|
-
|
|
Feb 04
2025
|
John Brendan Doyle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,000
+41.48%
|
-
|
|
Feb 04
2025
|
Anthony Caggiano Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,000
+41.04%
|
-
|
|
Feb 03
2025
|
Lisa Ricciardi CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
28,960
-9.94%
|
$0
$0.67 P/Share
|
|
Feb 03
2025
|
Anthony Caggiano Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,779
-9.02%
|
$0
$0.67 P/Share
|
|
Jan 31
2025
|
Lisa Ricciardi CEO & President |
BUY
Open market or private purchase
|
Indirect |
38,851
+50.0%
|
$0
$0.77 P/Share
|